vimarsana.com

Latest Breaking News On - Cyte corporation - Page 2 : vimarsana.com

OncoCyte (NASDAQ:OCX) Research Coverage Started at StockNews com

OncoCyte (NASDAQ:OCX) Research Coverage Started at StockNews com
wkrb13.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wkrb13.com Daily Mail and Mail on Sunday newspapers.

OncoCyte (NASDAQ:OCX) Receives New Coverage from Analysts at StockNews com

OncoCyte (NASDAQ:OCX) Receives New Coverage from Analysts at StockNews com
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

OncoCyte (NASDAQ:OCX) Coverage Initiated by Analysts at StockNews com

OncoCyte (NASDAQ:OCX) Coverage Initiated by Analysts at StockNews com
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

StockNews com Begins Coverage on OncoCyte (NASDAQ:OCX)

StockNews com Begins Coverage on OncoCyte (NASDAQ:OCX)
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

OncoCyte (NASDAQ:OCX) PT Raised to $4 25 at Needham & Company LLC

OncoCyte (NASDAQ:OCX – Get Free Report) had its target price increased by equities researchers at Needham & Company LLC from $3.60 to $4.25 in a research note issued to investors on Wednesday, Benzinga reports. The firm currently has a “buy” rating on the stock. Needham & Company LLC’s price target would suggest a potential upside […]

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.